Andrew Denny
Bristol-Myers Squibb
Executive Director, Predictive Quality
Andrew Denny is the Associate Director of Metrics and Knowledge Management for Bristol-Myers Squibb. He is responsible for the reporting of quality metrics within BMS as well as externally. In addition, he is leading efforts to develop and improve internal reporting metrics and processes. He has been working with the ISPE on compiling the industry response on the FDA Metrics guidance.
<br><br>
Beginning with Oneida Research Service, Wyeth Pharmaceuticals/Biopharma and Bristol-Myers Squibb, Andrew has 17 years of experience in the QC Laboratory with increasing responsibility. He has been in leadership roles responsible for testing of small molecule and large molecule products, leading quality systems activities, and playing a prominent role in regulatory inspections.
<br><br>
Andy holds a BA in Chemistry from State University of New York at Potsdam.
<br><br>
Beginning with Oneida Research Service, Wyeth Pharmaceuticals/Biopharma and Bristol-Myers Squibb, Andrew has 17 years of experience in the QC Laboratory with increasing responsibility. He has been in leadership roles responsible for testing of small molecule and large molecule products, leading quality systems activities, and playing a prominent role in regulatory inspections.
<br><br>
Andy holds a BA in Chemistry from State University of New York at Potsdam.